Structural studies on the Ebola virus matrix protein VP40 indicate that matrix proteins of enveloped RNA viruses are analogues but not homologues

FEMS Microbiology Letters

Volumn 233, Issue 2, 2004, Pages 179-186

  Timmins, Joanna ^a,b   Ruigrok, Rob W H ^a   Weissenhorn, Winfried ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (France)

^b EUROPEAN SYNCHROTRON RADIATION FACILITY   (France)

Author keywords

Ebola virus; HIV 1 MA; Influenza virus M1; Late domains; Matrix protein; VP40; VSV M

Indexed keywords

MATRIX PROTEIN; MATRIX PROTEIN VP40; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

EBOLA VIRUS; FILOVIRUS; GENETIC CONSERVATION; HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA VIRUS; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; RETROVIRUS; RNA VIRUS; SEQUENCE ANALYSIS; SHORT SURVEY; VESICULAR STOMATITIS VIRUS; VIRUS ASSEMBLY; VIRUS ENVELOPE; VIRUS MORPHOLOGY;

NUCLEOPROTEINS; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; RNA VIRUSES; VIRAL CORE PROTEINS;

EBOLA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA VIRUS; MARBURG-LIKE VIRUSES; RNA VIRUSES; VESICULAR STOMATITIS VIRUS;

EID: 1842530255     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.femsle.2004.03.002     Document Type: Short Survey

References (67)

1. Garoff H., Hewson R., Opstelten D.J. Virus maturation by budding. Microbiol Mol. Biol. Rev. 62:1998;1171-1190.
2. Schmitt, A.P. and Lamb, R.A. (2003) Escaping from the cell: assembly and budding of negative-strand RNA viruses. In: Reverse Genetics of Negative Stranded RNA Viruses (Y. Kawaoka, Ed.) Curr. Top. Microbiol. Immunol. (in press).
3. Justice P.A., Sun W., Li Y., Ye Z., Grigera P.R., Wagner R.R. Membrane vesiculation function and exocytosis of wild-type and mutant matrix proteins of vesicular stomatitis virus. J. Virol. 69:1995;3156-3160.
4. Timmins J., Scianimanico S., Schoehn G., Weissenhorn W. Vesicular release of ebola virus matrix protein VP40. Virology. 283:2001;1-6.
5. Jasenosky L.D., Neumann G., Lukashevich I., Kawaoka Y. Ebola virus VP40-induced particle formation and association with the lipid bilayer. J. Virol. 75:2001;5205-5214.
6. Krausslich H.G., Welker R. Intracellular transport of retroviral capsid components. Curr. Top. Microbiol. Immunol. 214:1996;25-63.
7. Scheiffele P., Rietveld A., Wilk T., Simons K. Influenza viruses select ordered lipid domains during budding from the plasma membrane. J. Biol. Chem. 274:1999;2038-2044.
8. Gottlinger H.G., Dorfman T., Sodroski J.G., Haseltine W.A. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl. Acad. Sci. USA. 88:1991;3195-3199.
9. Huang M., Orenstein J.M., Martin M.A., Freed E.O. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 69:1995;6810-6818.
10. Pornillos O., Garrus J.E., Sundquist W.I. Mechanisms of enveloped RNA virus budding. Trends Cell Biol. 12:2002;569-579.
11. Katzmann D.J., Odorizzi G., Emr S.D. Receptor downregulation and multivesicular-body sorting. Nat. Rev. Mol. Cell. Biol. 3:2002;893-905.
12. von Schwedler U.K., Stuchell M., Muller B., Ward D.M., Chung H.Y., Morita E., Wang H.E., Davis T., He G.P., Cimbora D.M., Scott A., Krausslich H.G., Kaplan J., Morham S.G., Sundquist W.I. The protein network of HIV budding. Cell. 114:2003;701-713.
13. Strack B., Calistri A., Craig S., Popova E., Gottlinger H.G. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell. 114:2003;689-699.
14. Patnaik A., Chau V., Wills J.W. Ubiquitin is part of the retrovirus budding machinery. Proc. Natl. Acad. Sci. USA. 97:2000;13069-13074.
15. Strack B., Calistri A., Accola M.A., Palu G., Gottlinger H.G. A role for ubiquitin ligase recruitment in retrovirus release. Proc. Natl. Acad. Sci. USA. 97:2000;13063-13068.
16. Harty R.N., Brown M.E., Wang G., Huibregtse J., Hayes F.P. A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc. Natl. Acad. Sci. USA. 97:2000;13871-13876.
17. Lafont F., Simons K. Raft-partitioning of the ubiquitin ligases Cbl and Nedd4 upon IgE-triggered cell signaling. Proc. Natl. Acad. Sci. USA. 98:2001;3180-3184.
18. Katzmann D.J., Sarkar S., Chu T., Audhya A., Emr S.D. Multivesicular body sorting: ubiquitin ligase Rsp5 is required for the modification and sorting of carboxypeptidase S. Mol. Biol. Cell. 15(2):2003;468-480.
19. Chatellard-Causse C., Blot B., Cristina N., Torch S., Missotten M., Sadoul R. Alix (ALG-2-interacting protein X), a protein involved in apoptosis, binds to endophilins and induces cytoplasmic vacuolization. J. Biol. Chem. 277:2002;29108-29115.
20. Wang M.Q., Kim W., Gao G., Torrey T.A., Morse 3rd H.C., De Camilli P., Goff S.P. Endophilins interact with Moloney murine leukemia virus Gag and modulate virion production. J. Biol. 3:2003;4.
21. Dessen A., Volchkov V., Dolnik O., Klenk H.D., Weissenhorn W. Crystal structure of the matrix protein VP40 from Ebola virus. EMBO J. 19:2000;4228-4236.
22. Ruigrok R.W., Schoehn G., Dessen A., Forest E., Volchkov V., Dolnik O., Klenk H.D., Weissenhorn W. Structural characterization and membrane binding properties of the matrix protein VP40 of Ebola virus. J. Mol. Biol. 300:2000;103-112.
23. Scianimanico S., Schoehn G., Timmins J., Ruigrok R.H., Klenk H.D., Weissenhorn W. Membrane association induces a conformational change in the Ebola virus matrix protein. EMBO J. 19:2000;6732-6741.
24. Timmins J., Schoehn G., Kohlhaas C., Klenk H.-D., Ruigrok R.W.H., Weissenhorn W. Oligomerization and polimerization of the filovirus matrix protein VP40. Virology. 312:2003;359-368.
25. Gomis-Ruth F.X., Dessen A., Timmins J., Bracher A., Kolesnikowa L., Becker S., Klenk H-D., Weissenhorn W. The matrix protein VP40 from Ebola virus octamerizes into pore-like structures with specific RNA binding properties. Structure (Cambridge). 11:2003;423-433.
26. Panchal R.G., Ruthel G., Kenny T.A., Kallstrom G.H., Lane D., Badie S.S., Li L., Bavari S., Aman M.J. In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding. Proc. Natl. Acad. Sci. USA. 100:2003;15936-15941.
27. Timmins J., Schoehn G., Ricard-Blum S., Scianimanico S., Vernet T., Ruigrok R.W., Weissenhorn W. Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4. J. Mol. Biol. 326:2003;493-502.
28. Yasuda J., Nakao M., Kawaoka Y., Shida H. Nedd4 regulates egress of Ebola virus-like particles from host cells. J. Virol. 77:2003;9987-9992.
29. Martin-Serrano J., Zang T., Bieniasz P.D. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat. Med. 7:2001;1313-1319.
30. Licata J.M., Simpson-Holley M., Wright N.T., Han Z., Paragas J., Harty R.N. Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4. J. Virol. 77:2003;1812-1819.
31. Gaudier M., Gaudin Y., Knossow M. Crystal structure of vesicular stomatitis virus matrix protein. EMBO J. 21:2002;2886-2892.
32. Gaudin Y., Sturgis J., Doumith M., Barge A., Robert B., Ruigrok R.W. Conformational flexibility and polymerization of vesicular stomatitis virus matrix protein. J. Mol. Biol. 274:1997;816-825.
33. McCreedy B.J. Jr., McKinnon K.P., Lyles D.S. Solubility of vesicular stomatitis virus M protein in the cytosol of infected cells or isolated from virions. J. Virol. 64:1990;902-906.
34. Gaudin Y., Barge A., Ebel C., Ruigrok R.W. Aggregation of VSV M protein is reversible and mediated by nucleation sites: implications for viral assembly. Virology. 206:1995;28-37.
35. Chong L.D., Rose J.K. Membrane association of functional vesicular stomatitis virus matrix protein in vivo. J. Virol. 67:1993;407-414.
36. Blondel D., Harmison G.G., Schubert M. Role of matrix protein in cytopathogenesis of vesicular stomatitis virus. J. Virol. 64:1990;1716-1725.
37. Petersen J.M., Her L.S., Varvel V., Lund E., Dahlberg J.E. The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes. Mol. Cell. Biol. 20:2000;8590-8601.
38. von Kobbe C., van Deursen J.M., Rodrigues J.P., Sitterlin D., Bachi A., Wu X., Wilm M., Carmo-Fonseca M., Izaurralde E. Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98. Mol. Cell. 6:2000;1243-1252.
39. Glodowski D.R., Petersen J.M., Dahlberg J.E. Complex nuclear localization signals in the matrix protein of vesicular stomatitis virus. J. Biol. Chem. 277:2002;46864-46870.
40. Kopecky S.A., Lyles D.S. The cell-rounding activity of the vesicular stomatitis virus matrix protein is due to the induction of cell death. J. Virol. 77:2003;5524-5528.
41. Newcomb W.W., Brown J.C. Role of the vesicular stomatitis virus matrix protein in maintaining the viral nucleocapsid in the condensed form found in native virions. J. Virol. 39:1981;295-299.
42. Huang Y., Xu L., Sun Y., Nabel G.J. The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein. Mol. Cell. 10:2002;307-316.
43. Harty R.N., Brown M.E., McGettigan J.P., Wang G., Jayakar H.R., Huibregtse J.M., Whitt M.A., Schnell M.J. Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction. J. Virol. 75:2001;10623-10629.
44. Sha B., Luo M. Structure of a bifunctional membrane-RNA binding protein, influenza virus matrix protein M1. Nat. Struct. Biol. 4:1997;239-244.
45. Arzt S., Baudin F., Barge A., Timmins P., Burmeister W., Ruigrok R.W.H. Combined results from solution studies on intact Influeenza virus M1 protein and from a new crystal form of its N-terminal domain show that M1 is an elongated monomer. Virology. 279:2001;439-446.
46. Baudin F., Petit I., Weissenhorn W., Ruigrok R.W. In vitro dissection of the membrane and RNP binding activities of influenza virus M1 protein. Virology. 281:2001;102-108.
47. Ye Z., Robinson D., Wagner R.R. Nucleus-targeting domain of the matrix protein (M1) of influenza virus. J. Virol. 69:1995;1964-1970.
48. Akarsu H., Burmeister W.P., Petosa C., Petit I., Muller C.W., Ruigrok R.W., Baudin F. Crystal structure of the M1 protein-binding domain of the influenza A virus nuclear export protein (NEP/NS2). EMBO J. 22:2003;4646-4655.
49. Gomez-Puertas P., Albo C., Perez-Pastrana E., Vivo A., Portela A. Influenza virus matrix protein is the major driving force in virus budding. J. Virol. 74:2000;11538-11547.
50. Enami M., Enami K. Influenza virus hemagglutinin and neuraminidase glycoproteins stimulate the membrane association of the matrix protein. J. Virol. 70:1996;6653-6657.
51. Zhang J., Lamb R.A. Characterization of the membrane association of the influenza virus matrix protein in living cells. Virology. 225:1996;255-266.
52. Martin K., Helenius A. Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell. 67:1991;117-130.
53. Hill C.P., Worthylake D., Bancroft D.P., Christensen A.M., Sundquist W.I. Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc. Natl. Acad. Sci. USA. 93:1996;3099-3104.
54. Rao Z., Belyaev A.S., Fry E., Roy P., Jones I.M., Stuart D.I. Crystal structure of SIV matrix antigen and implications for virus assembly. Nature. 378:1995;743-747.
55. McDonald D., Vodicka M.A., Lucero G., Svitkina T.M., Borisy G.G., Emerman M., Hope T.J. Visualization of the intracellular behavior of HIV in living cells. J. Cell Biol. 159:2002;441-452.
56. Haffar O.K., Popov S., Dubrovsky L., Agostini I., Tang H., Pushkarsky T., Nadler S.G., Bukrinsky M. Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex. J. Mol. Biol. 299:2000;359-368.
57. Conte M.R., Matthews S. Retroviral matrix proteins: a structural perspective. Virology. 246:1998;191-198.
58. Pornillos O., Higginson D.S., Stray K.M., Fisher R.D., Garrus J.E., Payne M., He G.P., Wang H.E., Morham S.G., Sundquist W.I. HIV Gag mimics the Tsg101-recruiting activity of the human Hrs protein. J. Cell Biol. 162:2003;425-434.
59. Skehel J.J., Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69:2000;531-569.
60. Weissenhorn W., Dessen A., Calder L.J., Harrison S.C., Skehel J.J., Wiley D.C. Structural basis for membrane fusion by enveloped viruses. Mol. Membr. Biol. 16:1999;3-9.
61. Rosenthal P.B., Zhang X., Formanowski F., Fitz W., Wong C.H., Meier-Ewert H., Skehel J.J., Wiley D.C. Structure of the haemagglutinin- esterase-fusion glycoprotein of influenza C virus. Nature. 396:1998;92-96.
62. Domingo E., Holland J.J. RNA virus mutations and fitness for survival. Annu. Rev. Microbiol. 51:1997;151-178.
63. Lyles D.S., McKenzie M.O., Kaptur P.E., Grant K.W., Jerome W.G. Complementation of M gene mutants of vesicular stomatitis virus by plasmid-derived M protein converts spherical extracellular particles into native bullet shapes. Virology. 217:1996;76-87.
64. Cathomen T., Mrkic B., Spehner D., Drillien R., Naef R., Pavlovic J., Aguzzi A., Billeter M.A., Cattaneo R. A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J. 17:1998;3899-3908.
65. Mebatsion T., Weiland F., Conzelmann K.K. Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G. J. Virol. 73:1999;242-250.
66. Kuhn R.J., Strauss J.H. Enveloped viruses. Adv. Protein Chem. 64:2003;363-377.
67. Stadler K., Masignani V., Eickmann M., Becker S., Abrignani S., Klenk H-D., Rappuoli R. SARS: beginning to understand a new virus. Nat. Rev. Microbiol. 1:2003;209-218.